Logo
x

Search

Subscribe Now

Licensing Agreement

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

  • October 13, 2021
Chugai and Sanofi to Terminate their Licensing Agreement for Tofogliflozin Hydrate in Japan

Chugai and Sanofi to Terminate their Licensing Agreement for Tofogliflozin Hydrate in Japan

  • February 18, 2020
Equillium Expands its Exclusive Licensing Agreement with Biocon for Itolizumab

Equillium Expands its Exclusive Licensing Agreement with Biocon for Itolizumab

  • December 13, 2019
Boehringer Ingelheim Enters into a Licensing Agreement with Lupin to Expand its KRAS Cancer Program

Boehringer Ingelheim Enters into a Licensing Agreement with Lupin to Expand its KRAS Cancer Program

  • September 4, 2019
Cantargia Extends Licensing Agreement with BioWa for its POTELLIGENT Technology

Cantargia Extends Licensing Agreement with BioWa for its POTELLIGENT Technology

  • August 23, 2019
Newsoara Biopharma Signs a Licensing Agreement with Zenith Epigenetics for its ZEN-3694

Newsoara Biopharma Signs a Licensing Agreement with Zenith Epigenetics for its ZEN-3694

  • August 7, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.